AMDA leadership weighs in on DEA’s telehealth medicine rules debate
By
Jessica R. Towhey
Aaron Dorman
Aug 10, 2023
The DEA may re-evaluate its rules on prescribing controlled substances via telehealth appointments, following a deluge of 38,000 public comments on the initial rulemaking.